BSIKX
Price
$9.70
Change
-$0.03 (-0.31%)
Updated
Jul 13 closing price
Net Assets
48.51B
NTBAX
Price
$9.68
Change
-$0.02 (-0.21%)
Updated
Jul 13 closing price
Net Assets
7.19B
Interact to see
Advertisement

BSIKX vs NTBAX

BSIKX vs NTBAX Comparison Chart in %
View a ticker or compare two or three
VS
BSIKX vs. NTBAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSIKX is a Hold and NTBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BSIKX has more cash in the bank: 48.5B vs. NTBAX (7.19B). BSIKX pays higher dividends than NTBAX: BSIKX (4.78) vs NTBAX (3.86). BSIKX was incepted earlier than NTBAX: BSIKX (10 years) vs NTBAX (12 years). NTBAX (1.30) is less costly to investors than BSIKX (0.64). BSIKX is a more actively managed with annual turnover of: 1006.00 vs. NTBAX (44.00). NTBAX has a lower initial minimum investment than BSIKX: NTBAX (5000) vs BSIKX (5000000). BSIKX annual gain was more profitable for investors over the last year : 5.69 vs. NTBAX (5.13). BSIKX return over 5 years is better than : 15.71 vs. NTBAX (8.47).
BSIKXNTBAXBSIKX / NTBAX
Total Expense Ratio0.631.2849%
Annual Report Gross Expense Ratio0.641.3049%
Fund Existence10 years12 years-
Gain YTD1.9191.620118%
Front LoadN/A4%-
Min. Initial Investment50000005000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets48.5B7.19B675%
Annual Yield % from dividends4.783.86124%
Returns for 1 year5.695.13111%
Returns for 3 years21.9016.43133%
Returns for 5 years15.718.47185%
Returns for 10 years44.2931.25142%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIERX33.21N/A
N/A
Putnam International Equity R
CIVVX25.02N/A
N/A
Causeway International Value Inv
EMECX17.29N/A
N/A
Ashmore Emerging Markets Equity C
BGETX14.41-0.18
-1.21%
Baillie Gifford International Growth 2
PFGEX29.53-0.46
-1.53%
Parnassus Growth Equity Investor